Under the terms of the agreement, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to Zydus, and Zydus will commercialise the drug in India, it added. "With India facing an acute shortage of the drug to treat mucormycosis, we are making this critical drug available in India on an immediate basis," Cadila Healthcare MD Sharvil Patel said.